Paul B Manning Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul B Manning.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul B Manning. Paul B Manning is a Director in AveXis, Inc. ($AVXS) and a Director in Verrica Pharmaceuticals Inc. ($VRCA) and a Director in Dova Pharmaceuticals, Inc. ($DOVA) and a Director in Taysha Gene Therapies, Inc. ($TSHA) and a Director in Liquidia Corp ($LQDA).
Address: C/O PERRIGO COMPANY 515 EASTERN AVENUE ALLEGAN 49010 MI
Companies in which Paul B Manning is an Insider
AveXis, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul B Manning: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2018
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dova Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul B Manning: Director
Holdings: 0 shares
Latest Transaction: Nov 12 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Liquidia Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul B Manning: Director
Holdings: 737,646 shares
Latest Transaction: Apr 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Taysha Gene Therapies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul B Manning: Director
Holdings: 12,000 shares
Latest Transaction: May 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verrica Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul B Manning: Director
Holdings: 739,830 shares
Latest Transaction: Mar 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul B Manning
Sentiment: All, AVXS, DOVA, LQDA, TSHA, VRCA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17 2021 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Buy | P | 20.98 | 12,000 | 251,760 | 12,000 | 0 to 12 K |
| Apr 15 2021 | LQDA | Liquidia Corp | Manning Paul B | Director | Buy | P | 2.52 | 198,413 | 500,001 | 737,646 | 539.2 K to 737.6 K (+36.80 %) |
| Mar 29 2021 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 14.75 | 739,830 | 10,912,493 | 739,830 | 0 to 739.8 K |
| Mar 26 2021 | LQDA | Liquidia Corp | Manning Paul B | Director | Option Exercise | A | 2.51 | 21,385 | 53,676 | 21,385 | |
| Nov 19 2020 | LQDA | Liquidia Corp | Manning Paul B | Director | Option Exercise | A | 3.38 | 30,000 | 101,400 | 30,000 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 10,963 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Option Exercise | C | 0.00 | 1,843,193 | 0 | 0 |